Welcome to our dedicated page for Tilray Brands news (Ticker: TLRY), a resource for investors and traders seeking the latest updates and insights on Tilray Brands stock.
Tilray Brands, Inc. operates as a global lifestyle and consumer packaged goods company spanning cannabis, craft beverages, hemp-based foods and wellness products. News about TLRY commonly covers product launches, brand refreshes and retail distribution across beverage and food subsidiaries such as BrewDog, 10 Barrel Brewing, SweetWater Brewing Company, Widmer Brothers Brewing and Manitoba Harvest.
Company updates also address Tilray Medical, international medical cannabis markets, Canadian adult-use and medical cannabis activity, quarterly operating results, acquisitions and capital actions. Recurring coverage links Tilray’s cannabis platform with its beverage and wellness portfolio across North America, Europe and other international markets.
Tilray, a leader in cannabis, announced that its German subsidiary, Aphria RX GmbH, successfully harvested medical cannabis in Germany, marking a key milestone for local production and distribution. This is the first harvest under EU Good Manufacturing Practices at their facility in Neumünster. The distribution complies with pharmaceuticals regulations, reducing reliance on imports for Germany's over 100,000 medical cannabis patients. Tilray's CEO emphasized the European market's growth potential, particularly in Germany, as they aim to enhance patient access to high-quality cannabis products.
Tilray has announced a collaboration between SweetWater Brewing Company and Broken Coast Cannabis to launch Broken Coast BC Lager, marking Tilray's first cannabis brand introduction in the U.S. The lager is crafted for beer enthusiasts and highlights the brands' commitment to quality. CEO Irwin D. Simon stated this partnership is a key milestone in their strategy to expand Canadian cannabis brands into the U.S. market. The new lager will be available on draft and in six-pack cans starting July 12, showcasing the growing intersection of cannabis and consumer products.
Tilray (NASDAQ | TSX: TLRY) has released a proxy statement urging shareholders to support key proposals at the Special Meeting scheduled for July 29, 2021. The company seeks to increase authorized shares of common stock to pursue growth through acquisitions and financing opportunities. Additionally, Tilray is proposing amendments to enhance shareholder rights following its merger with Aphria Inc. Shareholders on record as of June 22, 2021, are encouraged to vote by July 28, 2021, to ensure their voices are heard for these critical initiatives.
Tilray, a prominent cannabis-lifestyle company, has launched Symbios, a new medical brand in Canada, designed to enhance its product offerings. Symbios aims to provide a diverse range of formats and cannabinoid ratios at competitive prices, catering to medical patients’ health needs. Alongside this, Tilray introduced high-potency medical cannabis topicals under the Aphria brand targeting inflammatory joint diseases. CEO Irwin D. Simon emphasized innovation and patient care as key components of Tilray's global growth strategy, aiming to build on momentum across its medical brands.
Tilray (NASDAQ: TLRY) announced participation in two investor conferences in June 2021. The first is the Jefferies Virtual Healthcare Conference on June 1 at 8:30 AM ET, followed by the Stifel Cross Sector Insight Conference on June 8 at 4:00 PM ET. Webcast details will be available on the company’s website under the Investors section. Tilray is a pioneering global cannabis and consumer packaged goods company dedicated to enhancing well-being through high-quality products across various markets, including Canada, the US, Europe, and beyond.
Tilray announced its participation in the BMO Capital Markets 16th Annual Farm to Market Conference on May 19, 2021, with a presentation scheduled for 8:40 AM ET. Investors can access the conference details and webcast information through the Tilray website.
Tilray is a leading global cannabis-lifestyle company with operations in multiple regions, committed to enhancing well-being through high-quality products and innovative brands. The company aims to be a trusted partner for consumers, offering over 20 brands across more than 20 countries.
Tilray announced that its class 2 common stock (TLRY) began trading on the Toronto Stock Exchange as of May 5, 2021, while continuing to be listed on the Nasdaq. Following the merger with Aphria, shareholders of Aphria received 0.8381 Tilray Shares for each Aphria Share held as of April 30, 2021. Tilray aims to enhance well-being through its diverse portfolio of over 20 brands across various sectors, including cannabis, hemp, and alcoholic beverages, establishing itself as a leader in the global cannabis market.
Tilray and Aphria have successfully completed their business combination, forming the largest global cannabis-focused consumer packaged goods company with a market cap of about US$8.2 billion. Tilray Shares will trade on Nasdaq and the Toronto Stock Exchange under the ticker symbol 'TLRY'. Each Aphria shareholder received 0.8381 Tilray Shares for every Aphria share held. The company aims to leverage its operational scale, enhanced consumer presence, and substantial cost synergies of approximately US$81 million within 18 months, focusing on global growth and profitability.
Summary not available.
Tilray, Inc. (NASDAQ: TLRY) announced a bylaw amendment reducing the quorum requirement for shareholder meetings from a majority to one-third of voting power. This change is in connection with the proposed merger with Aphria Inc., allowing for shareholder votes at the upcoming special meeting on April 30. Tilray encourages all stockholders to participate in voting, regardless of share numbers. Proxies already submitted will be counted unless revoked. Tilray operates globally in cannabis research, cultivation, and distribution, serving thousands of customers across 17 countries.